NCT01801449View on ClinicalTrials.gov

Rilonacept for Deficiency of the Interleukin-1 Receptor Antagonist (DIRA)

PHASE2CompletedINTERVENTIONAL
Enrollment

6

Participants

Timeline

Start Date

February 12, 2013

Primary Completion Date

April 28, 2016

Study Completion Date

April 28, 2016

Conditions
DIRA
Interventions
DRUG

Rilonacept

Trial Locations (1)

20892

National Institutes of Health Clinical Center, 9000 Rockville Pike, Bethesda

All Listed Sponsors
collaborator

National Institutes of Health Clinical Center (CC)

NIH

lead

National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS)

NIH

NCT01801449 - Rilonacept for Deficiency of the Interleukin-1 Receptor Antagonist (DIRA) | Biotech Hunter | Biotech Hunter